Argyll Biotechnologies LLC
10% owner at IMMUNOSYN CORP
- Sold, on record
- $849B
- Dollars the filings state
- Form 4 sales
- 5
- Latest Mar 13, 2008
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- IMMUNOSYN CORP10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale IMMUNOSYN CORPPlan not statedApr 26, 2007 2007
Sold 412,100 shares at $2,060,500.00 ($849B)
Argyll Biotechnologies LLC, 10% owner
Sold 0.3% of holdings ($302894B position)147M shares leftFirst sale on recordFiling
- 2 Form 4 sale IMMUNOSYN CORPPlan not statedOct 18, 2007 +175 days
Sold 115,067 shares at $7.48 ($861k)
Argyll Biotechnologies LLC, 10% owner
Sold 0.1% of holdings ($1.1B position)146M shares leftFiling
- 3 Form 4 sale IMMUNOSYN CORPPlan not statedOct 24, 2007 +6 days
Sold 16,000 shares at $5.00 ($80k)
Argyll Biotechnologies LLC, 10% owner
Sold 0% of holdings ($729M position)146M shares leftFiling
- 4 Form 4 sale IMMUNOSYN CORPPlan not statedNov 1, 2007 +8 days
Sold 5,333 shares at $7.50 ($40k)
Argyll Biotechnologies LLC, 10% owner
Sold 0% of holdings ($1.1B position)146M shares left0x usual sizeFiling
- 5 Form 4 sale IMMUNOSYN CORPUnusualMar 13, 2008 +133 days
Sold 400,000 shares at $5.00 ($2M)
Argyll Biotechnologies LLC, 10% owner
Sold 0.3% of holdings ($729M position)145M shares left6.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2008 | Mar 20, 2008 | IMMUNOSYN CORP | 10% owner | Form 4 sale | 400,000 | $2M | 0.3% | Unusual | SEC |
| Nov 1, 2007 | Nov 5, 2007 | IMMUNOSYN CORP | 10% owner | Form 4 sale | 5,333 | $40k | 0.0% | Plan not stated | SEC |
| Oct 24, 2007 | Oct 26, 2007 | IMMUNOSYN CORP | 10% owner | Form 4 sale | 16,000 | $80k | 0.0% | Plan not stated | SEC |
| Oct 18, 2007 | Oct 22, 2007 | IMMUNOSYN CORP | 10% owner | Form 4 sale | 115,067 | $861k | 0.1% | Plan not stated | SEC |
| Apr 26, 2007 | Jul 13, 2007 | IMMUNOSYN CORP | 10% owner | Form 4 sale | 412,100 | $849B | 0.3% | Plan not stated | SEC |